OptiBiotix Health Plc (FRA:OB3)

Market Cap	6.26M -68.9%
Revenue (ttm)	1.34M +102.3%
Net Income	-222.82K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	50
Open	0.0580
Previous Close	0.0580
Day's Range	0.0580 - 0.0580
52-Week Range	0.0380 - 0.2300
Beta	n/a
RSI	33.90
Earnings Date	Jun 16, 2026

About OptiBiotix Health

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; C...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2006
• Employees: 10
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OB3

Financial Performance

In 2024, OptiBiotix Health's revenue was 870,000, an increase of 35.09% compared to the previous year's 644,000. Losses were -1.81 million, -11.48% less than in 2023.

Financial numbers in GBP